The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline.
According to Morgan Stanley's Matt Wilson, the 5,750-5,800 area — the convergence of the 200-day and 100-day moving averages — is the most critical technical test for the S&P 500 Index.
The pharma company saw a surge in retail sentiment following its Q1 update, which reaffirmed its 2025 revenue guidance of $900 million to $950 million.
The company projected 2025 oil production between 480,000 and 495,000 barrels of oil equivalent per day, a reduction of 1% at midpoint from its prior forecast.
The two companies announced plans to expand their autonomous vehicle partnership to 15 additional cities over the next five years, focusing on regions outside the U.S. and China.
CEO Kyle Gano highlighted record new patient starts for Ingrezza and noted positive early response to the launch of Crenessity, positioning the company for sustained growth.
U.S. commercial revenue surpassed a billion-dollar-annual-run-rate for the first time during the first quarter, while international commercial revenue saw some weakness.
Jeff Bezos explained that turning ideas into successful billion-dollar businesses like Amazon requires a unique blend of "stubborn relentlessness" and "flexibility," emphasizing the hard work and adaptability needed to bring ideas to life.
The Canadian Dollar (CAD) is holding steady against the US Dollar (USD) to kick off the new trading week, with USD/CAD holding steady near the 1.3800 handle.
Oil prices have been going through tough times. After logging the biggest monthly loss since 2021, oil prices tumbled below $60 per barrel for the first time since February 2021.
Without concrete trade deals from D.C., this rally stays tethered to headlines. The next leg will hinge on whichever way the Washington wind—and the FOMC rhetoric—finally blows.
HVAC company Trane (NYSE:TT) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 11.2% year on year to $4.69 billion. Its non-GAAP profit of $2.41 per share was 9.4% above analysts’ consensus estimates.
Fast-food company Yum! Brands (NYSE:YUM) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 11.8% year on year to $1.79 billion. Its non-GAAP profit of $1.30 per share was 1.4% above analysts’ consensus estimates.
Aerospace and defense company Howmet (NYSE:HWM) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.5% year on year to $1.94 billion. On the other hand, next quarter’s revenue guidance of $1.99 billion was less impressive, coming in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 11% above analysts’ consensus estimates.
